Averill LA
Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston.
ArticlePsychedelics
Mechanisms of Action and Change in Psychedelic-Assisted Therapies: A Holistic Framework for Ethical, Competent Clinical Care.
ArticleIbogaine
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology.
ArticlePsilocybin
Reported Safety Practices of Publicly Advertised Psychedelic Retreats.
ArticleKetamine
Combining DNA methylation features and clinical characteristics predicts ketamine treatment response for PTSD.
ArticlePsilocybin
Real-world use of classic and non-classic psychedelics in Hispanic/Latino adults with obsessive-compulsive disorder: international findings from the LATINO Study.
ArticleMDMA
Supportive Touch in Psychedelic Assisted Therapy.
ArticleDMT
5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study.
ArticleIbogaine
Open-label study of consecutive ibogaine and 5-MeO-DMT assisted-therapy for trauma-exposed male Special Operations Forces Veterans: prospective data from a clinical program in Mexico.
ArticleKetamine
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence.
ArticlePsilocybin
Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.
ArticleIbogaine
Prospective associations of psychedelic treatment for co-occurring alcohol misuse and posttraumatic stress symptoms among United States Special Operations Forces Veterans.
ArticlePsilocybin
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.
ArticlePsilocybin
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.
ArticleIbogaine